← Leaderboards
Christine Michelle Johnston
University Of Washington
$5,999,906
Attributed
$7,795,271
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2008–23$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$7,095,271 · 6
CDC$700,000 · 1
By mechanism
R01$2,693,048 · 1
P01$2,279,339 · 2
U19$1,028,129 · 1
U62$700,000 · 1
R56$603,653 · 1
K23$491,102 · 1
Top collaborators
- Martin C Darvas5 shared
- Cory Funk5 shared
Most similar at University Of Washington
Same institution · by research overlap
- Anna Wald$34,443,936
- Jeanne M Marrazzo$22,158,899
- David W Raible$21,473,931
- Martin C Darvas$3,115,484
- Cory Funk$897,683
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposInfectionSimplexvirusParticipantGenital SystemSwabRecurrenceLesionResponseHuman Herpesvirus 2Genital HerpesNatural HistoryInsightEnrollmentEpidemiologyPersonsRisk FactorsSkinPathogenesisBiopsyMucous MembranePatternImmune ResponseSite
Grant awards (26)
Modulation of Alzheimers disease by Herpes simplex virus infectionÂ$430,231
R01 · FY2023 · AG
Modulation of Alzheimers disease by Herpes simplex virus infectionÂ$513,438
R01 · FY2022 · AG
Modulation of Alzheimers disease by Herpes simplex virus infectionÂ$554,804
R01 · FY2021 · AG
Modulation of Alzheimers disease by Herpes simplex virus infectionÂ$575,841
R01 · FY2020 · AG
Modulation of Alzheimers disease by Herpes simplex virus infectionÂ$618,734
R01 · FY2019 · AG
Impact of HSV-2 shedding on the vaginal microbiome in the female genital tract$263,409
U19 · FY2018 · AI · contact PI
Clinical Core$322,914
P01 · FY2017 · AI · contact PI
Impact of HSV-2 shedding on the vaginal microbiome in the female genital tract$231,989
U19 · FY2017 · AI · contact PI
Genital HSV-1: An Emerging Disease$179,417
P01 · FY2017 · AI · contact PI
Clinical Core$264,356
P01 · FY2016 · AI · contact PI
Impact of HSV-2 shedding on the vaginal microbiome in the female genital tract$166,036
U19 · FY2016 · AI · contact PI
Genital HSV-1: An Emerging Disease$162,697
P01 · FY2016 · AI · contact PI
SEATTLE STD CLINICAL PREVENTION TRAINING CENTER$700,000
U62 · FY2015 · PS · contact PI
Clinical Core$267,290
P01 · FY2015 · AI · contact PI
Impact of HSV-2 shedding on the vaginal microbiome in the female genital tract$200,047
U19 · FY2015 · AI · contact PI
Genital HSV-1: An Emerging Disease$157,012
P01 · FY2015 · AI · contact PI
Clinical Core$320,804
P01 · FY2014 · AI · contact PI
Genital HSV-1: An Emerging Disease$166,961
P01 · FY2014 · AI · contact PI
Impact of HSV-2 shedding on the vaginal microbiome in the female genital tract$166,648
U19 · FY2014 · AI · contact PI
Clinical Core$287,324
P01 · FY2013 · AI · contact PI
Genital HSV-1: An Emerging Disease$150,564
P01 · FY2013 · AI · contact PI
Interaction between HSV-2 and the vaginal microbiome in the female genital tract$603,653
R56 · FY2012 · AI · contact PI
Dynamic Reactivation of Herpes Simplex Virus-2 and the Genital Mucosal Response$127,041
K23 · FY2011 · AI · contact PI
Dynamic Reactivation of Herpes Simplex Virus-2 and the Genital Mucosal Response$124,134
K23 · FY2010 · AI · contact PI
Dynamic Reactivation of Herpes Simplex Virus-2 and the Genital Mucosal Response$121,326
K23 · FY2009 · AI · contact PI
Dynamic Reactivation of Herpes Simplex Virus-2 and the Genital Mucosal Response$118,601
K23 · FY2008 · AI · contact PI